Investing.com -- Nvidia’s recent share weakness is puzzling given the strength of near-term expectations, according to Morgan Stanley, which says investors are asking why the stock has lagged despite a “very robust AI environment.” Morgan Stanley analyst Joseph Moore said they have been “somewhat surprised at Nvidia's underperformance YTD after a weak close to 2025,” noting that one of the most co...
Investing.com -- Nvidia’s recent share weakness is puzzling given the strength of near-term expectations, according to Morgan Stanley, which says investors are asking why the stock has lagged despite a “very robust AI environment.” Morgan Stanley analyst Joseph Moore said they have been “somewhat surprised at Nvidia's underperformance YTD after a weak close to 2025,” noting that one of the most common investor questions has been what is driving the pullback and how those overhangs will be resolved in 2026. The firm stated that its “checks remain very strong, and getting stronger,” and highlighted that bullish earnings assumptions are already widespread. Morgan Stanley is hearing “references to $9+ in earnings power this year, vs. consensus $7.75,” making near-term upside “highly likely.” The bank argued that several concerns weighing on sentiment are overstated. It said “the number of AI beneficiaries are broadening out” as demand surges and supply shortages spread across the sector. Some investors are also focused on financing for frontier model developers and “NVIDIA's role in that financing,” which Morgan Stanley stated requires “some adjustment.” Concerns around competitive dynamics with ASICs and AMD persist but are “overblown,” the firm believes. A key catalyst, according to Morgan Stanley, will be the upcoming Vera Rubin platform, which should offer a “strong demonstration of NVIDIA's leadership” and help address share concerns. “The bottom line is that we see the stock outperforming from here,” Moore wrote, adding that Nvidia still faces a “wall of worry to climb” but is positioned to move past it. Related articles Nvidia stock: Morgan Stanley explains what it will take for shares to outperform Gold may hit $5,000/oz in 1H'26 - HSBC HSBC raises silver price forecasts as market tightness persists
Hollencrest Capital Management grew its stake in shares of Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:TSM - Free Report) by 125.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,216 shares of the semiconductor company's stock after purchasing an additional 2,901 shares durin...
Hollencrest Capital Management grew its stake in shares of Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:TSM - Free Report) by 125.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,216 shares of the semiconductor company's stock after purchasing an additional 2,901 shares during the quarter. Hollencrest Capital Management's holdings in Taiwan Semiconductor Manufacturing were worth $1,457,000 as of its most recent filing with the Securities and Exchange Commission. Other hedge funds and other institutional investors have also made changes to their positions in the company. Heartwood Wealth Advisors LLC purchased a new position in shares of Taiwan Semiconductor Manufacturing during the third quarter worth approximately $32,000. Resources Management Corp CT ADV purchased a new position in Taiwan Semiconductor Manufacturing during the 2nd quarter worth $32,000. Mid American Wealth Advisory Group Inc. acquired a new position in Taiwan Semiconductor Manufacturing in the second quarter valued at $33,000. First Command Advisory Services Inc. boosted its stake in shares of Taiwan Semiconductor Manufacturing by 174.1% during the second quarter. First Command Advisory Services Inc. now owns 159 shares of the semiconductor company's stock worth $36,000 after buying an additional 101 shares during the period. Finally, Fairman Group LLC grew its holdings in shares of Taiwan Semiconductor Manufacturing by 171.2% during the third quarter. Fairman Group LLC now owns 141 shares of the semiconductor company's stock worth $39,000 after buying an additional 89 shares during the last quarter. Institutional investors and hedge funds own 16.51% of the company's stock. Get TSM alerts: Sign Up Taiwan Semiconductor Manufacturing Stock Performance TSM opened at $342.18 on Thursday. Taiwan Semiconductor Manufacturing Company Ltd. has a 1-year low of $134.25 and a 1-year high...
watch now VIDEO 6:16 06:16 After ICE violence, CEOs face the risks of speaking out against Trump Markets and Politics Digital Original Video The fatal shooting this weekend of a second American citizen by federal immigration agents in Minnesota has forced corporate leaders to do something they've rarely done since President Donald Trump returned to office last year: publicly disagree with his poli...
watch now VIDEO 6:16 06:16 After ICE violence, CEOs face the risks of speaking out against Trump Markets and Politics Digital Original Video The fatal shooting this weekend of a second American citizen by federal immigration agents in Minnesota has forced corporate leaders to do something they've rarely done since President Donald Trump returned to office last year: publicly disagree with his policies. For months, executives have kept quiet as the Trump administration expanded its sprawling immigration crackdown. The Department of Homeland Security in recent weeks has sent thousands of U.S. Immigration and Customs Enforcement and Border Patrol agents into Minnesota, leading to violent clashes with protestors. It wasn't until the Jan. 24 killing of intensive care unit nurse Alex Pretti by federal agents that more CEOs started to break their year of near silence on the president's actions. The following day, dozens of executives from Minnesota-based corporations co-signed a letter calling for an " immediate de-escalation " in the state. Even then, it was clear the business leaders were treading carefully — they didn't mention the name of the shooting victim, the president by name or his policies. Instead of speaking out individually, they published the message as a group. The reluctance of business leaders — among the most powerful and wealthiest Americans — to explicitly speak out against the president's policies illustrates how Trump has used his power during his second term. Trump has sued media companies, law firms, universities and banks, and he has threatened corporations with regulatory scrutiny and the review of lucrative government contracts. "They don't want to speak out alone because they are afraid," Jeffrey Sonnenfeld , a Yale School of Management professor, told CNBC. "They know that they will be shaken down, coerced, intimidated [by the administration]. Retaliatory gestures are quite severe." In subzero temperatures, demonstrators marched in downtown Mi...
Key Points AI could make it faster and easier to develop drugs. Eli Lilly is looking to lead this transformation. There are many additional reasons to invest in the stock. 10 stocks we like better than Eli Lilly › Artificial intelligence (AI) is impacting, and will eventually impact, nearly every sector and industry, including pharmaceuticals. Companies are already using AI to speed up drug discov...
Key Points AI could make it faster and easier to develop drugs. Eli Lilly is looking to lead this transformation. There are many additional reasons to invest in the stock. 10 stocks we like better than Eli Lilly › Artificial intelligence (AI) is impacting, and will eventually impact, nearly every sector and industry, including pharmaceuticals. Companies are already using AI to speed up drug discovery. But how long will it take to have a significant impact on the market? According to some projections, within five years, the U.S. Food and Drug Administration (FDA) will approve the first drug developed using AI. And by 2030, more than 50% of new medicines approved will have been developed with AI assistance. The companies at the forefront of this transformation could see their profits and stock prices soar. But which is the top stock to consider to cash in on this opportunity? In my view, the answer is Eli Lilly (NYSE: LLY). Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks » Eli Lilly is hard at work The point of AI-driven drug discovery isn't that the technology will magically uncover new miracle drugs. The impact will likely be more modest, but also meaningful. Going from early-stage discovery to human clinical trials to approvals takes years, sometimes over a decade, plus hundreds of millions of dollars of investment and plenty of failures along the way. If AI can help reduce the failure rate and the time spent across the various phases of development by even 5%, that will cut research and development (R&D) costs, raise margins, boost profits, and lead to lower-cost drugs. Everyone wins. Over the past year, Eli Lilly has accelerated its AI-related efforts. The company is building what will become the pharmaceutical industry's most powerful AI supercomputer, with the assistance of Nvidia (NASDAQ: NVDA). While other companies ahead of the pharmaceutic...
VSE ( VSEC ), a provider of aftermarket distribution and repair services for the aviation industry, on Thursday said it would acquire Precision Aviation Group ( PAG ) for a total upfront consideration of about $2.025 billion in cash and equity. The deal consists of $1.75 billion in cash and about $275 million of equity consideration issued to GenNx, VSEC said. In addition, the company added that t...
VSE ( VSEC ), a provider of aftermarket distribution and repair services for the aviation industry, on Thursday said it would acquire Precision Aviation Group ( PAG ) for a total upfront consideration of about $2.025 billion in cash and equity. The deal consists of $1.75 billion in cash and about $275 million of equity consideration issued to GenNx, VSEC said. In addition, the company added that the agreement includes up to $125 million in additional contingent earnout consideration, payable in cash or equity consideration at VSE’s sole discretion, based on PAG’s 2026 adjusted EBITDA performance. VSEC’s shares rose over 2% in premarket trading on Thursday. Atlanta, Georgia-based PAG, which is a portfolio company of GenNx360 Capital Partners, was founded in 1996. It is a provider of maintenance, repair, and overhaul services, distribution, and supply chain solutions for the aviation sector. “This transformational transaction is expected to expand our scale significantly, increase our proprietary solutions content, and further strengthen our position as a mission-critical partner to aviation operators worldwide,” said VSEC CEO John Cuomo. PAG, which serves both commercial and defense end markets, expects to generate about $615 million of adjusted revenue for the fiscal year ended December 31, 2025. Precision Aviation Group’s adjusted EBITDA margin is expected to be immediately accretive to VSE’s consolidated Adjusted EBITDA margin, it said. The transaction is expected to close in the second quarter of 2026. VSEC also said it expects revenue of about $290M to $304M and operating income of about $27M to $34M for the fourth quarter. For fiscal year 2025, the company’s revenue is expected to range from about $1,101M to $1,115M, with operating income of about $84M to $91M. Consensus for fourth quarter and FY25 revenue are $283.34M and $1.09B. More on VSE VSE Corporation: M&A As An Aerospace Growth Engine VSE Corporation: High Valuation Coupled With Stock Dilution And Poor ...
watch now VIDEO 8:29 08:29 'More likely than not' U.S. will launch a strike on Iran, says Amos Hochstein Squawk Box Crude oil prices rose more than 2% on Thursday as President Donald Trump weighed military strikes on OPEC member Iran. U.S. crude rose $1.56, or 2.5%, to $64.77 per barrel. Global benchmark Brent was up $1.59, or 2.3%, to $69.99 per barrel. Multiple sources told Reuters that Trump is...
watch now VIDEO 8:29 08:29 'More likely than not' U.S. will launch a strike on Iran, says Amos Hochstein Squawk Box Crude oil prices rose more than 2% on Thursday as President Donald Trump weighed military strikes on OPEC member Iran. U.S. crude rose $1.56, or 2.5%, to $64.77 per barrel. Global benchmark Brent was up $1.59, or 2.3%, to $69.99 per barrel. Multiple sources told Reuters that Trump is weighing targeted strikes on Iranian security forces and leaders to inspire anti-government protestors. The president wants to create conditions for regime change, two U.S. sources told Reuters. The Islamic Republic launched a security crackdown earlier this month to quell protests, leaving thousands dead. The oil market is monitoring whether the unrest in Iran and possible military intervention by the U.S. could lead to a disruption of crude supplies in the region. Trump has deployed the Abraham Lincoln Carrier Strike Group to the Middle East, warnings Iran on Wednesday that time is running out to make a deal on its nuclear program. The president threatened Tehran with larger strikes than the attack the U.S. launched last June, which targeted Iran's nuclear facilities. "The next attack will be far worse! Don't make that happen again," Trump said in a Truth Social post.
Paragon Advisors LLC bought a new position in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 9,342 shares of the company's stock, valued at approximately $1,829,000. A number of other hedge funds have also recently added to or reduced their stakes in the business. TD W...
Paragon Advisors LLC bought a new position in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 9,342 shares of the company's stock, valued at approximately $1,829,000. A number of other hedge funds have also recently added to or reduced their stakes in the business. TD Waterhouse Canada Inc. boosted its stake in Astera Labs by 7.0% in the third quarter. TD Waterhouse Canada Inc. now owns 16,434 shares of the company's stock valued at $2,946,000 after acquiring an additional 1,073 shares during the period. one8zero8 LLC bought a new position in Astera Labs in the 3rd quarter worth about $323,000. Mirae Asset Global Investments Co. Ltd. increased its position in Astera Labs by 16,543.5% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 196,560 shares of the company's stock valued at $38,486,000 after acquiring an additional 195,379 shares during the period. Federated Hermes Inc. raised its stake in Astera Labs by 91.9% during the 3rd quarter. Federated Hermes Inc. now owns 278,305 shares of the company's stock valued at $54,492,000 after acquiring an additional 133,305 shares in the last quarter. Finally, Truist Financial Corp grew its stake in shares of Astera Labs by 270.0% in the third quarter. Truist Financial Corp now owns 35,062 shares of the company's stock worth $6,865,000 after purchasing an additional 25,585 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company's stock. Get Astera Labs alerts: Sign Up Astera Labs Price Performance NASDAQ:ALAB opened at $167.90 on Thursday. Astera Labs, Inc. has a one year low of $47.13 and a one year high of $262.90. The company has a fifty day moving average price of $163.38 and a 200 day moving average price of $170.80. The stock has a market cap of $28.36 billion, a P/E ratio of 151.26, a PEG ratio of 2.33 and a beta of 1.50. Astera Labs...
凌晨,OpenAI 发布了新一代 AI 科研利器 Prism,该平台由 GPT-5.2 加持,供科学家们撰写和协作研究,即日起向所有拥有 ChatGPT 个人账户的用户免费开放。用华人 AI 创业者 Yuchen Jin 的话说,“每篇论文都将把 ChatGPT 列为合著者。” 而在昨日,OpenAI 副总裁、新成立的 OpenAI for Science 团队负责人 Kevin Weil 就在 ...
凌晨,OpenAI 发布了新一代 AI 科研利器 Prism,该平台由 GPT-5.2 加持,供科学家们撰写和协作研究,即日起向所有拥有 ChatGPT 个人账户的用户免费开放。用华人 AI 创业者 Yuchen Jin 的话说,“每篇论文都将把 ChatGPT 列为合著者。” 而在昨日,OpenAI 副总裁、新成立的 OpenAI for Science 团队负责人 Kevin Weil 就在 X 上发文预热道,“我们的目标是赋予每位科学家 AI 超能力,让他们能做更多事情,让世界在 2030 年就能开展 2050 年的科学研究。” 自 ChatGPT 爆红面世后的三年里,OpenAI 的技术颠覆了日常生活中方方面面的行为模式。如今 OpenAI 正明确发力科研领域,面向科研人员布局。10 月,该公司宣布成立全新的 OpenAI for Science 团队,核心致力于探索其大语言模型(LLM)助力科研人员的路径,并优化旗下工具为科研人员提供支持。过去数月,社交媒体上涌现出大量相关内容,学术期刊也刊发了诸多研究成果,数学家、物理学家、生物学家等领域研究者纷纷撰文,讲述大语言模型、尤其是 GPT-5 如何助力他们取得新发现或是为他们指引方向,让他们找到原本可能错失的解决方案。 那么,OpenAI 为何选择此时入局?此番布局,究竟想要达成怎样的目标?发力科研领域,与该公司更宏大的使命如何契合?在这一领域,OpenAI 已然姗姗来迟。谷歌 DeepMind 早在数年前便已成立 AI-for-science 团队,打造了 AlphaFold、AlphaEvolve 等具有开创性的科学模型。2023 年,谷歌 DeepMind 的 CEO 兼联合创始人 Demis Hassabis 曾就该团队的情况在采访中表示,“这是我创立 DeepMind 的初衷。事实上,这也是我整个职业生涯深耕 AI 领域的原因。” 近日,Kevin Weil 在一次访谈中不仅正面回应了这些问题,还对当前模型的实际能力给出了比先前更为保守的评价:目前模型还达不到取得颠覆性新发现的水平,但倘若能让人不必把时间浪费在已经解决的问题上,也是对科研的一种加速。有意思的是,据其透露,一位 OpenAI 主动接触且开通了 GPT-5 付费服务的科研人员反馈,GPT-5 会犯一些低级错误,比人犯的错误更加愚蠢,不过...
Qualcomm and AMD are reportedly considering the integration of SOCAMM2 memory into their AI product lines to enhance memory capacity and speed. Following NVIDIA's "Vera" CPU , which features LPDDR5X memory on the SOCAMM factor, offering 1.2 TB/s of memory bandwidth and supporting up to 1.5 TB of LPDDR5X memory, Qualcomm and AMD aim to pursue a similar strategy to achieve high-speed, high-capacity ...
Qualcomm and AMD are reportedly considering the integration of SOCAMM2 memory into their AI product lines to enhance memory capacity and speed. Following NVIDIA's "Vera" CPU , which features LPDDR5X memory on the SOCAMM factor, offering 1.2 TB/s of memory bandwidth and supporting up to 1.5 TB of LPDDR5X memory, Qualcomm and AMD aim to pursue a similar strategy to achieve high-speed, high-capacity AI systems. These systems require fast memory close to AI accelerators, and SOCAMM can complement the extensive HBM memory on the accelerators. It acts as a fast memory pool with sufficient capacity to store entire models in memory, reducing the need for data transfer to SSD flash storage.NVIDIA's SOCAMM approach involves surrounding the CPU with multiple SOCAMM modules, a strategy Qualcomm and AMD are expected to adopt in their AI solutions. AMD's Instinct MI accelerators, paired with EPYC CPUs, might be the next candidates for this integration, or AMD may develop a completely new system. Qualcomm already offers AI solutions like the AI200 and AI250 inference accelerators, which include up to 768 GB of LPDDR5 per card. These could soon be complemented by SOCAMM, allowing for standardized memory expansion based on the SOCAMM standard rather than soldering individual memory modules. This approach would enable manufacturers to offer various system versions and solutions by simply adding or removing SOCAMM modules, without the need for extensive PCB soldering work.
(RTTNews) - CIVISTA BANCSHARES, INC. (CIVB) revealed a profit for fourth quarter that Drops, from the same period last year The company's bottom line came in at $12.26 million, or $0.61 per share. This compares with $46.21 million, or $2.64 per share, last year. Excluding items, CIVISTA BANCSHARES, INC. reported adjusted earnings of $15.12 million or $0.75 per share for the period. The company's r...
(RTTNews) - CIVISTA BANCSHARES, INC. (CIVB) revealed a profit for fourth quarter that Drops, from the same period last year The company's bottom line came in at $12.26 million, or $0.61 per share. This compares with $46.21 million, or $2.64 per share, last year. Excluding items, CIVISTA BANCSHARES, INC. reported adjusted earnings of $15.12 million or $0.75 per share for the period. The company's revenue for the period fell 74.8% to $55.74 million from $220.98 million last year. CIVISTA BANCSHARES, INC. earnings at a glance (GAAP) : -Earnings: $12.26 Mln. vs. $46.21 Mln. last year. -EPS: $0.61 vs. $2.64 last year. -Revenue: $55.74 Mln vs. $220.98 Mln last year. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
(RTTNews) - Potomac Bancshares, Inc. (PTBS) revealed a profit for its fourth quarter that Increases, from the same period last year The company's earnings came in at $2.37 million, or $0.57 per share. This compares with $1.97 million, or $0.48 per share, last year. Excluding items, Potomac Bancshares, Inc. reported adjusted earnings of $2.17 million or $0.52 per share for the period. The company's...
(RTTNews) - Potomac Bancshares, Inc. (PTBS) revealed a profit for its fourth quarter that Increases, from the same period last year The company's earnings came in at $2.37 million, or $0.57 per share. This compares with $1.97 million, or $0.48 per share, last year. Excluding items, Potomac Bancshares, Inc. reported adjusted earnings of $2.17 million or $0.52 per share for the period. The company's revenue for the period rose 17.3% to $12.77 million from $10.89 million last year. Potomac Bancshares, Inc. earnings at a glance (GAAP) : -Earnings: $2.37 Mln. vs. $1.97 Mln. last year. -EPS: $0.57 vs. $0.48 last year. -Revenue: $12.77 Mln vs. $10.89 Mln last year. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Key Points Analysts have price targets as low as $140 and as high as $352 for Nvidia. The stock is trading for just 25 times forward earnings, but it could be even lower than that. With momentum pushing profit estimates higher, it's hard to bet against the bulls here. 10 stocks we like better than Nvidia › Analyst opinions on Nvidia (NASDAQ: NVDA) are like noses, and not just because everybody has...
Key Points Analysts have price targets as low as $140 and as high as $352 for Nvidia. The stock is trading for just 25 times forward earnings, but it could be even lower than that. With momentum pushing profit estimates higher, it's hard to bet against the bulls here. 10 stocks we like better than Nvidia › Analyst opinions on Nvidia (NASDAQ: NVDA) are like noses, and not just because everybody has one. Sometimes they run. Sometimes they're stuffy. Sometimes they just need to breathe. There are dozens of Wall Street pros following the country's most valuable company by market cap. Their near-term price targets are everywhere, like noses, I guess. Let's see what these analysts are banking on in terms of price targets. Then, let's pivot to why these near-term opinions might not matter. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » The price is right How high or low do analysts think Nvidia could go in the next 12 months? Equity research firm Evercore ISI has a Street-high target of $352, bumping it up from $261 back in November. At the bearish end of the spectrum, Seaport Global Securities is perched at $140. The goal was actually boosted from $100 two months ago. It's a world of extreme outcomes. If Evercore is right, there's 84% upside for Nvidia shareholders from its Monday close of $191.52. If Seaport scores, Nvidia stock would take a 27% hit. The median of all the analyst profit targets is $250, a reasonable 31% higher than where the undeniable leader of the artificial intelligence (AI) revolution stands today. These estimates are all over the map, and that's a good thing. Whether you're long or short Nvidia, you don't want the complacency of every Wall Street pro hovering around the same projections. Thankfully for those who own Nvidia, there's a good reason to believe that Nvidia could exceed even the rosiest of expectations. Beauty and the beat You know Nvidia is respected ...
US Treasuries fluctuated as investors looked ahead to jobs data for clues on the path of interest rates and surging commodity prices kindled concerns about sticky inflation. The yield on 30-year Treasuries was two basis points higher at 4.87% after rising three basis points earlier in the day. The 10-year government note was steady, leaving the yield at around 4.25%. Bonds are posting small moves ...
US Treasuries fluctuated as investors looked ahead to jobs data for clues on the path of interest rates and surging commodity prices kindled concerns about sticky inflation. The yield on 30-year Treasuries was two basis points higher at 4.87% after rising three basis points earlier in the day. The 10-year government note was steady, leaving the yield at around 4.25%. Bonds are posting small moves after the Federal Reserve fueled speculation it’s in no hurry to ease. Officials said they would need to see greater confidence on inflation before considering cuts, pushing back against expectations for aggressive near-term easing. The potential for price growth to accelerate remains a concern as Brent crude futures hit $70 a barrel for the first time since September. US President Donald Trump warned Iran to make a nuclear deal or face military strikes. Inflation “will remain sticky and not disinflate from here,” said Kevin Flanagan, head of fixed income strategy at WisdomTree. “It’s fair to see at some stage 10-year yields back near 4.5% and the 30-year around 5%.”
Sundry Photography/iStock Editorial via Getty Images Shares of Lam Research ( LRCX ) rose about 4% premarket on Thursday after fiscal second quarter results and outlook surpassed estimates, drawing positive reactions from analysts. RBC Capital Markets kept its Outperform rating on Lam and raised the price target to $290 from $260, noting that strong wafer fabrication equipment, or WFE, and favorab...
Sundry Photography/iStock Editorial via Getty Images Shares of Lam Research ( LRCX ) rose about 4% premarket on Thursday after fiscal second quarter results and outlook surpassed estimates, drawing positive reactions from analysts. RBC Capital Markets kept its Outperform rating on Lam and raised the price target to $290 from $260, noting that strong wafer fabrication equipment, or WFE, and favorable technology transitions drove the company's solid outlook. "LRCX reported strong Dec-25Q results driven by healthy WFE environment and share gains. Management sees ~23% WFE growth in 2026, above our expectations, and believes that the company can continue to outgrow the market. While NAND spending remains lumpy, LRCX has made solid progress in Foundry and is benefiting from CoWoS/HBM [Chip-on-Wafer-on-Substrate/High Bandwidth Memory] strength," said analysts led by Srini Pajjuri. The analysts expect WFE momentum to sustain into 2027 on the back of generative AI, or GenAI, demand and extreme supply tightness in memory. Tech transitions such as MolyB, Backside Power, and 4F2 offer additional tailwinds, the analysts added. Morgan Stanley maintained its Equal-weight rating on Lam but increased the price target on the shares to $244 from $211. "We are in an unprecedented period for WFE, and LAM’s 2026 WFE guidance surpassed even bullish expectations. With multiple levers for outperformance, we expect LAM to continueexecuting across all fronts," said analysts led by Shane Brett. The analysts noted that Lam's earnings were not necessarily a surprise. However, the company’s forward-looking industry commentary significantly exceeded expectations. Lam guided to 2026 WFE growth of 23% (from $110B to $135B), driven by strength in DRAM and leading-edge logic. Brett and his team noted that this compares favorably with their prior WFE growth forecast of 16%. The analysts added that Lam's management also indicated that risk is skewed to the upside, noting that “basically every customer i...